Method for assisting diagnosis of secondary progressive multiple sclerosis, and method for screening for therapeutic agent for multiple sclerosis
Patent Information
- Application Number
- JP2025549112
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Priority Date
- 2023-09-26
- Filing Date
- 2024-09-26
- Publication Date
- 2025-04-03
AI Technical Summary
Current treatments for secondary progressive multiple sclerosis (SPMS) are limited, and the role of intestinal bacteria in the progression of the disease has not been fully analyzed, necessitating a method for diagnosing SPMS and screening therapeutic agents.
Identifying Tyzzerella nexilis as a bacterial species with increased abundance in SPMS patients, using its relative abundance to diagnose SPMS and evaluating therapeutic agents by determining their ability to inactivate or reduce Tyzzerella nexilis, potentially through endolysin derived from the bacterium.
Provides a method for diagnosing SPMS and screening therapeutic agents that can potentially suppress neuroinflammation by targeting Tyzzerella nexilis, offering a novel approach to treating the disease.